share_log

'Theriva Biologics Has Received A Notice Of Allowance For Its U.S. Patent Application 16/982,211 Titled "Alkaline Phosphatase Agents For Treatment Of Radiation Disorders"' - USPTO

'Theriva Biologics Has Received A Notice Of Allowance For Its U.S. Patent Application 16/982,211 Titled "Alkaline Phosphatase Agents For Treatment Of Radiation Disorders"' - USPTO

“Theriva Biologics 已收到美国专利申请 16/982,211 的许可通知,该专利名为 “用于治疗辐射障碍的碱性磷酸酶药物” '-USPTO
Benzinga Real-time News ·  2023/01/23 12:07

'Theriva Biologics Has Received A Notice Of Allowance For Its U.S. Patent Application 16/982,211 Titled "Alkaline Phosphatase Agents For Treatment Of Radiation Disorders"' - USPTO

“Theriva Biologics 已收到美国专利申请 16/982,211 的许可通知,该专利名为 “用于治疗辐射障碍的碱性磷酸酶药物” '-USPTO

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发